Farewell to Benjamin Gowen, Hong Ma, and Rachel Valenzuela

Benjamin Gowen joined our lab as a Postdoctoral Fellow in May 2015 and used the CRISPR/Cas9 system to study T cell regulation. Congratulations on his big step in becoming the Co-Founder and CEO at Peregrine Biotechnology, Inc. Wishing you much luck on your new business venture.

Hong Ma joined the lab as a Research Associate I in February 2016. She has accepted a Research Associate II position in Kramer Lab. Best wishes as you embark on a new challenge.

Rachel Valenzuela joined the IGI staff as a Postdoctoral Fellow in July 2016, and used the CRISPR/Cas9 system to study the factors involved in metabolic disorders in human and mouse models. She will be a Cell Line Engineer at Memphis Meats. Best of luck in your new job!

SUBMIT A COMMENT

Your email address will not be published. Required fields are marked *

Filters

Latest News

January 30, 2025

C-TERMINAL AMIDES FUNCTION AS SIGNALS FOR PROTEIN DEGRADATION- PUBLISHED IN NATURE

Proteins are essential building blocks of life, but they can become toxic to our cells if damaged, for example under oxidative stress. In turn, human cells ...

January 20, 2025

Congratulations to Zac who was awarded an ETH grant!

We are thrilled to announce that GEML has been awarded an ETH grant to advance its pioneering research into the biological mechanisms driving phenotypic variability...

January 16, 2025

Congratulations to Charles and Lilly on the BRIDGE Discovery grant!

We’re happy to announce that Charles and Lilly received the BRIDGE Discovery supporting HT-DISCOVER, an exciting new technology for detecting genome...

News Archive

Tweets